179.63
price up icon1.01%   1.80
after-market Dopo l'orario di chiusura: 179.63
loading
Precedente Chiudi:
$177.83
Aprire:
$177.86
Volume 24 ore:
819.34K
Relative Volume:
0.67
Capitalizzazione di mercato:
$19.81B
Reddito:
$9.54B
Utile/perdita netta:
$841.00M
Rapporto P/E:
24.14
EPS:
7.44
Flusso di cassa netto:
$1.02B
1 W Prestazione:
-0.05%
1M Prestazione:
+3.63%
6M Prestazione:
+18.98%
1 anno Prestazione:
+31.23%
Intervallo 1D:
Value
$177.21
$179.75
Intervallo di 1 settimana:
Value
$175.64
$180.24
Portata 52W:
Value
$136.30
$182.38

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
Nome
Quest Diagnostics Inc
Name
Telefono
(973) 520-2700
Name
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Name
Dipendente
56,000
Name
Cinguettio
@QuestDX
Name
Prossima data di guadagno
2025-04-22
Name
Ultimi documenti SEC
Name
DGX's Discussions on Twitter

Confronta DGX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
179.63 19.81B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
405.46 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.54 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
536.34 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
118.01 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
157.59 27.64B 15.50B 1.33B 2.16B 7.34

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-02 Iniziato Redburn Atlantic Buy
2025-03-04 Downgrade Citigroup Buy → Neutral
2025-01-06 Aggiornamento Leerink Partners Market Perform → Outperform
2024-12-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2024-12-10 Ripresa Jefferies Buy
2024-10-23 Aggiornamento Robert W. Baird Neutral → Outperform
2024-08-28 Ripresa Evercore ISI In-line
2024-07-10 Aggiornamento Citigroup Neutral → Buy
2024-02-26 Iniziato Leerink Partners Market Perform
2024-02-07 Aggiornamento Jefferies Hold → Buy
2024-01-03 Iniziato Barclays Equal Weight
2023-12-12 Aggiornamento BofA Securities Neutral → Buy
2023-06-29 Iniziato Piper Sandler Neutral
2023-05-02 Downgrade BofA Securities Buy → Neutral
2023-04-03 Aggiornamento Citigroup Sell → Neutral
2023-01-23 Iniziato Evercore ISI In-line
2022-11-17 Downgrade Citigroup Neutral → Sell
2022-08-22 Ripresa Morgan Stanley Equal-Weight
2022-04-04 Downgrade Citigroup Buy → Neutral
2022-02-23 Downgrade UBS Buy → Neutral
2022-02-02 Downgrade Jefferies Buy → Hold
2022-01-28 Downgrade Deutsche Bank Buy → Hold
2021-05-04 Aggiornamento UBS Neutral → Buy
2021-03-12 Downgrade Robert W. Baird Outperform → Neutral
2020-10-21 Aggiornamento Argus Hold → Buy
2020-07-29 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 Aggiornamento BofA Securities Neutral → Buy
2020-06-09 Aggiornamento Wells Fargo Underweight → Equal Weight
2020-06-02 Aggiornamento Deutsche Bank Hold → Buy
2020-04-28 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-04-27 Aggiornamento Citigroup Neutral → Buy
2020-04-27 Aggiornamento Wolfe Research Underperform → Peer Perform
2020-03-27 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-01-08 Iniziato Wells Fargo Underweight
2020-01-07 Downgrade Barclays Overweight → Equal Weight
2019-12-19 Aggiornamento BofA/Merrill Underperform → Neutral
2019-07-15 Downgrade Goldman Neutral → Sell
2019-04-02 Aggiornamento Jefferies Hold → Buy
2019-03-18 Ripresa Credit Suisse Neutral
2019-01-31 Downgrade Argus Buy → Hold
2019-01-17 Iniziato UBS Neutral
2019-01-03 Downgrade BofA/Merrill Neutral → Underperform
2018-12-03 Downgrade BofA/Merrill Buy → Neutral
2018-11-30 Downgrade Goldman Buy → Neutral
Mostra tutto

Quest Diagnostics Inc Borsa (DGX) Ultime notizie

pulisher
Jun 17, 2025

DGX Stock Up on New Blood Test Development Deal With MD Anderson - TradingView

Jun 17, 2025
pulisher
Jun 16, 2025

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga

Jun 16, 2025
pulisher
Jun 13, 2025

Quest Diagnostics stock hits all-time high of $180.11 By Investing.com - Investing.com Canada

Jun 13, 2025
pulisher
Jun 11, 2025

Quest Diagnostics and University of Texas want to promote more cancer screenings - Mugglehead Magazine

Jun 11, 2025
pulisher
Jun 11, 2025

Fecal Immunochemical Diagnostic Test (FIT) Market Top - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

Quest Diagnostics (DGX) Collaborates with MD Anderson for Cancer Risk Test Development | DGX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Quest Diagnostics New Blood Test Could Transform Early Cancer Detection for 9 Major Cancers - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Quest Diagnostics Incorporated : The stock forcefully approaches new pivot levels - MarketScreener

Jun 10, 2025
pulisher
Jun 09, 2025

Quest Diagnostics (DGX) Stock Analysis: Navigating a 5.5% Upside with Strong Revenue Growth - DirectorsTalk Interviews

Jun 09, 2025
pulisher
Jun 03, 2025

Transcript : Quest Diagnostics Incorporated Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10 - marketscreener.com

Jun 03, 2025
pulisher
Jun 02, 2025

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term - Yahoo Finance

Jun 02, 2025
pulisher
May 28, 2025

Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 28, 2025
pulisher
May 27, 2025

Quest Diagnostics (DGX) Participates in Upcoming Oppenheimer Meeting | DGX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick? - The Globe and Mail

May 27, 2025
pulisher
May 23, 2025

Is Wall Street Bullish or Bearish on Quest Diagnostics Stock? - inkl

May 23, 2025
pulisher
May 23, 2025

Is Wall Street Bullish Or Bearish On Quest Diagnostics Stock? - Barchart.com

May 23, 2025
pulisher
May 22, 2025

Quest Diagnostics' $4M Rest Break Settlement Gets Initial OK - Law360

May 22, 2025
pulisher
May 22, 2025

Quest Diagnostics (DGX) Announces Results of 2025 Annual Meeting of Stockholders - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Quest Diagnostics Inc (DGX) Shares Gap Down to $171.44 on May 21 - GuruFocus

May 22, 2025
pulisher
May 21, 2025

What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year? - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

Quest Diagnostics stock hits all-time high of $179.37 By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 19, 2025

Director Diaz Luis was granted 1,203 shares, increasing direct ownership by 42% to 4,054 units (SEC Form 4) - Quantisnow

May 19, 2025
pulisher
May 16, 2025

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference - PR Newswire

May 16, 2025
pulisher
May 16, 2025

Lung Cancer Diagnostics Market Outlook: Opportunities in Early - openPR.com

May 16, 2025
pulisher
May 16, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Insider Sell: Mark Delaney Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Quest Diagnostics Keeps Dividend at $0.80 per Share, Payable July 21 to Shareholders as of July 7 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Quest Diagnostics (DGX) Declares Consistent Dividend - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Quest Diagnostics Declares Quarterly Cash Dividend - PR Newswire

May 14, 2025
pulisher
May 14, 2025

Quest Diagnostics : Forbes Names Quest Diagnostics One of America's Best Large Employers - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Is Quest Diagnostics Incorporated's (NYSE:DGX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Yahoo

May 13, 2025
pulisher
May 13, 2025

Should You Continue to Retain DGX Stock in Your Portfolio? - TradingView

May 13, 2025
pulisher
May 13, 2025

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds - Quantisnow

May 13, 2025
pulisher
May 11, 2025

DGX Q1 Earnings Call: Acquisitions, Advanced Diagnostics, and Operational Initiatives Drive Growth - Yahoo Finance

May 11, 2025
pulisher
May 08, 2025

Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

May 08, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Sees Raised Target Price by JP Morgan | - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

May 06, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Receives Price Target Increase from JPMo - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - MSN

May 06, 2025
pulisher
May 03, 2025

Quest Diagnostics Stock: A Leader But Waiting For Better Price (NYSE:DGX) - Seeking Alpha

May 03, 2025
pulisher
May 02, 2025

Quest Settles Fired Black Phlebotomist's Retaliation Suit - Law360

May 02, 2025
pulisher
May 01, 2025

Bullish on Quest Diagnosis Inc. - The Globe and Mail

May 01, 2025
pulisher
Apr 30, 2025

This Company Extended Its Post-Earnings Rally to Record Highs - The Globe and Mail

Apr 30, 2025
pulisher
Apr 29, 2025

Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters

Apr 29, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook By Investing.com - Investing.com Canada

Apr 28, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook - Investing.com

Apr 28, 2025

Quest Diagnostics Inc Azioni (DGX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Quest Diagnostics Inc Azioni (DGX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
DELANEY MARK E
SVP & Chief Commercial Officer
May 13 '25
Sale
175.31
874
153,221
7,498
diagnostics_research WAT
$349.04
price down icon 0.96%
diagnostics_research LH
$262.51
price up icon 0.74%
$168.94
price up icon 0.58%
diagnostics_research MTD
$1,174.72
price down icon 0.83%
diagnostics_research IQV
$157.59
price up icon 0.08%
Capitalizzazione:     |  Volume (24 ore):